1. Adelaide Research & Scholarship

Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 19 (Search time: 0.021 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2014Brain natriuretic peptide: a biomarker for all cardiac disease?Mahadavan, G.; Nguyen, T.; Horowitz, J.
2014Aging of the nitric oxide system: are we as old as our NO?Sverdlov, A.; Ngo, D.; Chan, W.; Chirkov, Y.; Horowitz, J.
2014Interactions between inflammatory activation and endothelial dysfunction selectively modulate valve disease progression in patients with bicuspid aortic valveAli, O.; Chapman, M.; Thanh, H.; Chirkov, Y.; Heresztyn, T.; Mundisugih, J.; Horowitz, J.
2014High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: Insights from the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trialHijazi, Z.; Siegbahn, A.; Andersson, U.; Granger, C.; Alexander, J.; Atar, D.; Gersh, B.; Mohan, P.; Harjola, V.; Horowitz, J.; Husted, S.; Hylek, E.; Lopes, R.; McMurray, J.; Wallentin, L.
2014Systematic review and meta-analysis of incidence and correlates of recurrence of takotsubo cardiomyopathySingh, K.; Carson, K.; Usmani, Z.; Sawhney, G.; Shah, R.; Horowitz, J.
2014Meta-analysis of clinical correlates of acute mortality in takotsubo cardiomyopathySingh, K.; Carson, K.; Shah, R.; Sawhney, G.; Singh, B.; Parsaik, A.; Gilutz, H.; Usmani, Z.; Horowitz, J.
2014Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trialWallentin, L.; Hijazi, Z.; Andersson, U.; Alexander, J.; De Caterina, R.; Hanna, M.; Horowitz, J.; Hylek, E.; Lopes, R.; Åsberg, S.; Granger, C.; Siegbahn, A.
2014Prolonged impact of home versus clinic-based management of chronic heart failure: extended follow-up of a pragmatic, multicentre randomized trial cohortStewart, S.; Carrington, M.; Horowitz, J.; Marwick, T.; Newton, P.; Davidson, P.; Macdonald, P.; Thompson, D.; Chan, Y.; Krum, H.; Reid, C.; Scuffham, P.
2014High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarinHijazi, Z.; Wallentin, L.; Siegbahn, A.; Andersson, U.; Alexander, J.; Atar, D.; Gersh, B.; Hanna, M.; Harjola, V.; Horowitz, J.; Husted, S.; Hylek, E.; Lopes, R.; McMurray, J.; Granger, C.
2014Thioredoxin-interacting protein: pathophysiology and emerging pharmacotherapeutics in cardiovascular disease and diabetesChong, C.; Chan, W.; Nguyen, T.; Liu, S.; Procter, N.; Ngo, D.; Sverdlov, A.; Chirkov, Y.; Horowitz, J.

Discover